We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/OB/GYN & Women's Health

OB/GYN & Women's Health

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Estrogen Therapy Linked to Improved Survival in Certain Ovarian Cancer Patients Under 60
newssurvival outcomesovarian cancer

Estrogen Therapy Linked to Improved Survival in Certain Ovarian Cancer Patients Under 60

By MedXY|Aug 18, 2026

Study shows post-diagnosis estrogen therapy improves survival in high-grade serous and clear cell ovarian cancers but may worsen outcomes in endometrioid subtypes, offering guidance for managing menopausal symptoms in younger survivors.

Low-Dose Aspirin’s Pregnancy Benefit Appears Unchanged by Start Time or Adherence in a Large Multicentre Post Hoc Trial Analysis
OB/GYN & Women's HealthadherencePregnancy

Low-Dose Aspirin’s Pregnancy Benefit Appears Unchanged by Start Time or Adherence in a Large Multicentre Post Hoc Trial Analysis

By MedXY|Aug 18, 2026

In this post hoc analysis of a large randomized pregnancy trial, aspirin’s effects on preterm birth and perinatal mortality were not meaningfully modified by gestational age at initiation or measured adherence.

First-Trimester Maternal CMV Infection Concentrates the Risk of Fetal Brain Injury, Hearing Loss, and Autism Spectrum Disorder
Infectious Diseasesfetal MRIfirst trimester

First-Trimester Maternal CMV Infection Concentrates the Risk of Fetal Brain Injury, Hearing Loss, and Autism Spectrum Disorder

By MedXY|Aug 18, 2026

A large prospective cohort suggests that long-term sequelae of congenital CMV after primary maternal infection are confined to first-trimester exposure, with autism spectrum disorder linked to temporal lobe white matter abnormalities.

Real-world Evidence: Managing Platelet Counts in Ovarian Cancer Patients on First-Line Maintenance Niraparib
newsreal‑world evidenceplatelet monitoring

Real-world Evidence: Managing Platelet Counts in Ovarian Cancer Patients on First-Line Maintenance Niraparib

By MedXY|Aug 18, 2026

A US cohort study of 543 ovarian cancer patients revealed 37% experienced decreased platelets during niraparib maintenance. Onset typically occurred within 1 month but resolved rapidly with dose adjustments, resulting in low discontinuation

Antenatal Prediction of Shoulder Dystocia and Birth Trauma Using Routine Maternal and Ultrasound Variables
newsantenatal predictionbirth trauma

Antenatal Prediction of Shoulder Dystocia and Birth Trauma Using Routine Maternal and Ultrasound Variables

By MedXY|Aug 18, 2026

A retrospective UK study of 24,334 pregnancies developed predictive models for shoulder dystocia and birth trauma using maternal characteristics and fetal abdominal circumference, showing improved accuracy over current methods.

Hematologic Response to Iron Therapy and Stillbirth Risk in Moderate Iron Deficiency Anemia
Hematology-Oncologyiron therapystillbirth prevention

Hematologic Response to Iron Therapy and Stillbirth Risk in Moderate Iron Deficiency Anemia

By MedXY|Aug 18, 2026

Study reveals inadequate hemoglobin improvement at 20-24 weeks after iron therapy increases stillbirth and preterm birth risks in moderate iron deficiency anemia pregnancies, highlighting need for early intervention.

HPV Self-Sampling May Expand Cervical Cancer Screening Access for Transmasculine and Nonbinary Patients
newsCervical Cancer Screeningnonbinary patients

HPV Self-Sampling May Expand Cervical Cancer Screening Access for Transmasculine and Nonbinary Patients

By MedXY|Aug 18, 2026

A narrative review suggests HPV self-sampling is acceptable and potentially practice-changing for transmasculine and nonbinary people who are often underscreened for cervical cancer.

Higher PFAS Exposure During Pregnancy Was Not Linked to Increased Gestational Diabetes in the ECHO Cohort
Diabetes & EndocrinologyPregnancyPFAS

Higher PFAS Exposure During Pregnancy Was Not Linked to Increased Gestational Diabetes in the ECHO Cohort

By MedXY|Aug 18, 2026

In a pooled U.S. pregnancy cohort, maternal PFAS concentrations were not associated with a higher prevalence of gestational diabetes, and fasting glucose findings were largely null.

Real-World Antibody-Drug Conjugate Outcomes in Gynecologic Cancers Appear Consistent Across Demographic Subgroups
newshealth disparitiesgynecologic cancers

Real-World Antibody-Drug Conjugate Outcomes in Gynecologic Cancers Appear Consistent Across Demographic Subgroups

By MedXY|Aug 18, 2026

In a single-center real-world cohort, survival with mirvetuximab soravtansine, trastuzumab deruxtecan, and tisotumab vedotin broadly mirrored pivotal trials, with no independent survival differences by age, race, or ethnicity after adjustme

Pregnancy Outcomes Among Individuals With Cerebral Palsy: A Population-Based Cohort Study
Neurologymaternal health妊娠成績

Pregnancy Outcomes Among Individuals With Cerebral Palsy: A Population-Based Cohort Study

By MedXY|Aug 18, 2026

Canadian research reveals individuals with cerebral palsy face significantly higher risks of severe maternal complications, preterm birth, and neonatal issues during pregnancy, highlighting the need for specialized perinatal care.

Gut Microbiome Signatures May Help Explain Why Gestational Diabetes Raises Later Type 2 Diabetes Risk in Hispanic/Latina Women
Diabetes & Endocrinologygut microbiomeHispanic/Latina women

Gut Microbiome Signatures May Help Explain Why Gestational Diabetes Raises Later Type 2 Diabetes Risk in Hispanic/Latina Women

By MedXY|Aug 18, 2026

In HCHS/SOL, prior gestational diabetes was linked to a proinflammatory gut microbiome, adverse metabolite patterns, and higher future type 2 diabetes risk, suggesting a plausible microbiome-mediated pathway after pregnancy.

Danish Multicenter Study Finds a 15% ADNEX Threshold Best Balances Early Detection and Referral Burden for Adnexal Masses
newsIOTA ADNEXovarian cancer triage

Danish Multicenter Study Finds a 15% ADNEX Threshold Best Balances Early Detection and Referral Burden for Adnexal Masses

By MedXY|Aug 18, 2026

In a Danish multicenter cohort of adnexal masses, IOTA-based models outperformed RMI for routine triage. A 15% ADNEX threshold best balanced sensitivity and referral burden in non-tertiary care.

Early Pregnancy Oxylipin Biomarkers Linked to Fetal Growth Restriction Patterns
newsfetal developmentgrowth restriction

Early Pregnancy Oxylipin Biomarkers Linked to Fetal Growth Restriction Patterns

By MedXY|Aug 18, 2026

Study reveals specific inflammation and oxidative stress markers in early pregnancy urine predict distinct fetal growth restriction patterns, offering potential for early detection and intervention strategies.

Early Pregnancy Oxylipins Point to Distinct Inflammatory and Oxidative Stress Signals in Fetal Growth Restriction
newsoxylipinsoxidative stress

Early Pregnancy Oxylipins Point to Distinct Inflammatory and Oxidative Stress Signals in Fetal Growth Restriction

By MedXY|Aug 18, 2026

Early pregnancy urinary oxylipins linked inflammatory and oxidative stress pathways to small-for-gestational-age birth, with distinct signatures for early- and late-onset growth restriction. Associations with large-for-gestational-age birth

newscervical cancerHPV

New Cervical Cancer Screening Guidelines: Patient-Collected HPV Tests Now Recommended

By MedXY|Apr 30, 2026

Introduction and Context Despite being highly preventable, cervical cancer remains a significant health threat. The…

Prolonged TSH Suppression in Postmenopausal Thyroid Cancer Patients Linked to Worse Cardiovascular and Quality-of-Life Outcomes
Cardiologycardiovascular riskdifferentiated thyroid cancer

Prolonged TSH Suppression in Postmenopausal Thyroid Cancer Patients Linked to Worse Cardiovascular and Quality-of-Life Outcomes

By MedXY|Apr 30, 2026

Study finds long-term TSH suppression in postmenopausal women with thyroid cancer correlates with poorer cardiovascular health, reduced quality of life, and increased osteoporosis risk compared to controls.

Six-Fold Higher Cardiovascular Risk: Eclampsia’s Early Postpartum Threat Demands Urgent Clinical Attention
Cardiologycardiovascular diseaseeclampsia

Six-Fold Higher Cardiovascular Risk: Eclampsia’s Early Postpartum Threat Demands Urgent Clinical Attention

By MedXY|Apr 18, 2026

A nationwide study reveals that eclampsia patients face a 6.9-fold increased risk of cardiovascular disease readmission within the first year postpartum, with stroke risk nearly 13 times higher than normotensive patients. These findings und

Most Women Have Anterior-Apical Prolapse, But Phenotype Does Not Predict Recurrence After Native Tissue Repair
newsApical prolapse surgeryNative tissue repair

Most Women Have Anterior-Apical Prolapse, But Phenotype Does Not Predict Recurrence After Native Tissue Repair

By MedXY|Apr 14, 2026

A combined analysis of 704 women found that anterior-predominant and apical prolapse is the most common phenotype (67.2%) in women undergoing native tissue apical surgery. While symptomatic recurrence ranged from 0% to 29% across phenotype

Longer Wait, Higher Risk? How Timing of Hypertensive Disorder Diagnosis Shapes Women’s Cardiovascular Future
Cardiologycardiovascular riskexpectant management

Longer Wait, Higher Risk? How Timing of Hypertensive Disorder Diagnosis Shapes Women’s Cardiovascular Future

By MedXY|Apr 14, 2026

New research reveals that longer latency between hypertensive disorder of pregnancy diagnosis and delivery correlates with subtle inflammatory and lipid changes in young mothers, suggesting subclinical cardiovascular risk elevation years af

Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes
newsEndometrial Cancermolecular biomarkers

Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes

By MedXY|Apr 9, 2026

A real-world study of 671 endometrial cancer patients reveals significant molecular heterogeneity. PTEN, ARID1A, and PIK3CA are the most prevalent biomarkers, while TP53 mutations and ERBB2 amplification cluster in advanced-stage and non-en

Prev
12 / 24
1…1011121314…24
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles